Cancer drugs may remain approved despite lack of benefit

Reuters Health, Andrew M. Seaman
Dec 5, 2016
1 min read

In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies show them to be inferior to other options or even worse than doing nothing, a new study found.

Read the full article here.

#News

Recent Posts

See All

USA Patient Network Joins Patient Advocates in Joint Response to FDA Regarding Materials Used in Im

How the FDA Handles Recalls of Life-Saving Implants Could Put People at Risk, Patients Say

Jonesboro resident Geraldine Robinson is one of millions of Americans who use an implanted medical device to improve, and possibly extend...

USA Patient Network Responds to Right To Try Legislation

We believe that there is no need for the proposed Right To Try Legislation (RTT). A pathway to such access already exists through the FDA’s

Comments